Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
0.174
-0.002 (-0.85%)
At close: Feb 21, 2025, 4:00 PM
0.175
+0.001 (0.29%)
After-hours: Feb 21, 2025, 7:47 PM EST
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $4.68 million as of February 21, 2025. Its market cap has decreased by -97.01% in one year.
Market Cap
4.68M
Enterprise Value
6.63M
1-Year Change
-97.01%
Ranking
Category
Stock Price
$0.17
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from $413.10M to $4.68M, a decrease of -98.87%. That is a compound annual growth rate of -40.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 4.70M | -24.19% |
| Dec 31, 2024 | 6.20M | -96.22% |
| Dec 29, 2023 | 164.10M | 126.03% |
| Dec 30, 2022 | 72.60M | -64.04% |
| Dec 31, 2021 | 201.90M | -59.38% |
| Dec 31, 2020 | 497.00M | 69.45% |
| Dec 31, 2019 | 293.30M | 56.43% |
| Dec 31, 2018 | 187.50M | -26.73% |
| Dec 29, 2017 | 255.90M | -9.99% |
| Dec 30, 2016 | 284.30M | -31.18% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.92B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |